Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-10 Purchase | 2023-03-14 4:09 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 6,779 | $2.5956 | $17,596 | 20,777,343 (Indirect) | View |
| 2023-02-08 Purchase | 2023-02-10 4:22 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 1,500,000 | $2.6 | $3,900,000 | 20,770,564 (Indirect) | View |
| 2023-01-30 Purchase | 2023-02-01 4:26 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 184,272 | $4.9986 | $921,110 | 21,981,782 (Indirect Direct) | View |
| 2023-01-23 Purchase | 2023-01-25 4:26 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 9,900 | $4.9994 | $49,494 | 21,797,510 (Indirect Direct) | View |
| 2023-01-19 Purchase | 2023-01-23 4:21 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 69,739 | $2.4979 | $174,201 | 19,270,564 (Indirect) | View |
| 2023-01-19 Purchase | 2023-01-23 4:16 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 38,139 | $4.9976 | $190,603 | 21,787,610 (Indirect Direct) | View |
| 2023-01-17 Purchase | 2023-01-19 4:13 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 185,151 | $2.5105 | $464,827 | 19,200,825 (Indirect) | View |
| 2023-01-12 Purchase | 2023-01-17 4:31 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 5,378 | $4.9466 | $26,603 | 21,749,471 (Indirect Direct) | View |
| 2023-01-10 Purchase | 2023-01-12 4:32 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 309,070 | $4.7865 | $1,479,359 | 21,744,093 (Indirect Direct) | View |
| 2022-12-12 Purchase | 2022-12-14 4:24 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 300 | $4.9767 | $1,493 | 21,435,023 (Indirect Direct) | View |
| 2022-11-21 Purchase | 2022-11-23 4:11 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 40,327 | $4.9988 | $201,588 | 21,434,723 (Indirect Direct) | View |
| 2022-11-21 Purchase | 2022-11-23 4:11 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 9,615,384 | $2.6 | $24,999,998 | 19,015,674 (Indirect) | View |
| 2022-11-03 Purchase | 2022-11-07 4:16 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 139,148 | $4.9187 | $684,427 | 21,394,396 (Indirect Direct) | View |
| 2022-10-27 Purchase | 2022-10-31 5:20 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 76,877 | $4.8602 | $373,638 | 21,255,248 (Indirect Direct) | View |
| 2022-10-25 Purchase | 2022-10-27 6:52 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 123,820 | $4.8088 | $595,428 | 21,178,371 (Indirect Direct) | View |
| 2022-10-17 Purchase | 2022-10-19 6:02 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 130,000 | $3.5569 | $462,396 | 21,054,551 (Indirect Direct) | View |
| 2022-06-09 Purchase | 2022-06-13 4:56 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 984,161 | $13.5 | $13,286,174 | 18,274,374 (Indirect Direct) | View |
| 2022-06-02 Purchase | 2022-06-06 4:40 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 34,200 | $13.03 | $445,739 | 18,241,897 (Indirect Direct) | View |
| 2022-05-31 Purchase | 2022-06-02 4:22 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 153,806 | $13.46 | $2,069,667 | 18,240,768 (Indirect Direct) | View |
| 2022-05-26 Purchase | 2022-05-31 4:58 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 22,911 | $13.49 | $309,035 | 18,235,692 (Indirect Direct) | View |
| 2022-05-25 Purchase | 2022-05-27 4:24 pm | RAPT Therapeutics Inc. | RAPT | COLUMN GROUP II LP Column Group II GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V Svennilson Peter Column Group LLC 10% Owner | 1,900 | $12.45 | $23,664 | 3,189,178 (Indirect Direct) | View |
| 2022-05-24 Purchase | 2022-05-26 4:07 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 61,120 | $13.42 | $819,948 | 18,234,936 (Indirect Direct) | View |
| 2022-05-23 Purchase | 2022-05-25 4:19 pm | RAPT Therapeutics Inc. | RAPT | COLUMN GROUP II LP Column Group II GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V Svennilson Peter Column Group LLC 10% Owner | 26,550 | $12.19 | $323,745 | 3,189,115 (Indirect Direct) | View |
| 2022-05-19 Purchase | 2022-05-23 4:10 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 39,700 | $13.36 | $530,454 | 18,232,919 (Indirect Direct) | View |
| 2022-05-17 Purchase | 2022-05-19 4:33 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 151,699 | $13.33 | $2,022,004 | 18,231,609 (Indirect Direct) | View |
| 2022-05-13 Purchase | 2022-05-17 4:18 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 162,531 | $2.6327 | $427,891 | 18,226,603 (Indirect Direct) | View |
| 2022-05-11 Purchase | 2022-05-13 5:27 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 166,350 | $11.43 | $1,902,032 | 18,221,240 (Indirect Direct) | View |
| 2022-05-10 Purchase | 2022-05-12 5:28 pm | RAPT Therapeutics Inc. | RAPT | COLUMN GROUP II LP Column Group II GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V Svennilson Peter Column Group LLC 10% Owner | 1,250,000 | $10.67 | $13,339,375 | 3,188,239 (Indirect Direct) | View |
| 2022-05-09 Purchase | 2022-05-11 6:01 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 114,440 | $10.95 | $1,252,982 | 18,215,750 (Indirect Direct) | View |
| 2022-01-24 Purchase | 2022-01-26 7:07 pm | NGM BIOPHARMACEUTICALS INC | NGM | GOEDDEL DAVID V Director 10% Owner | 849,701 | $0 | $0 | 18,211,973 (Indirect Direct) | View |
| 2021-09-27 Sale | 2021-09-29 4:58 pm | RAPT Therapeutics Inc. | RAPT | COLUMN GROUP II LP Column Group II GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V Svennilson Peter Column Group LLC 10% Owner | 9,239 | $34.57 | $319,397 | 3,169,979 (Indirect Direct) | View |
| 2021-09-14 Sale | 2021-09-16 5:16 pm | RAPT Therapeutics Inc. | RAPT | COLUMN GROUP II LP Column Group II GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V Svennilson Peter Column Group LLC 10% Owner | 181,211 | $37.01 | $6,707,218 | 3,146,989 (Indirect Direct) | View |
| 2021-09-10 Sale | 2021-09-14 5:31 pm | RAPT Therapeutics Inc. | RAPT | COLUMN GROUP II LP Column Group II GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V Svennilson Peter Column Group LLC 10% Owner | 36,055 | $35.22 | $1,269,950 | 5,126,883 (Indirect Direct) | View |
| 2021-09-01 Sale | 2021-09-03 4:09 pm | RAPT Therapeutics Inc. | RAPT | COLUMN GROUP II LP Column Group II GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V Svennilson Peter Column Group LLC 10% Owner | 68,850 | $35.34 | $2,433,143 | 4,313,583 (Indirect Direct) | View |
| 2021-08-20 Sale | 2021-08-24 8:52 pm | RAPT Therapeutics Inc. | RAPT | COLUMN GROUP II LP Column Group II GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V Svennilson Peter Column Group LLC 10% Owner | 95,746 | $31.3 | $2,996,516 | 4,313,583 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion